Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10329298 Inhibitors of cellular metabolic processes

Patent 10329298 was granted and assigned to Agios Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12077534 Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer
0
Edits on 25 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent RE49934 Inhibitors of cellular metabolic processes
0
Edits on 9 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 9 Dec, 2023
Edits made to:
Article (+196 characters)
Article

Patent abstract

The present disclosure provides MAT2A inhibitor compounds that are useful as therapeutic agents for treating malignancies, and wherein the compounds conform to general formula (IA):

Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1032929800
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 4 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 4 Apr, 2023
Edits on 31 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 31 Mar, 2023
Edits on 29 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Mar, 2023
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10329298
Edits on 19 May, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11325914 Inhibitors of cellular metabolic processes
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11046691 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
Edits on 7 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 7 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10800782 Inhibitors of cellular metabolic processes
Edits on 6 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10738056 Pyrazolopyrimidinone compounds and uses thereof
Edits on 27 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 27 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10329298 Inhibitors of cellular metabolic processes

Infobox
Is a
Patent
Patent
Patent applicant
Agios Pharmaceuticals
Agios Pharmaceuticals
Current assignee
Agios Pharmaceuticals
Agios Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10329298
Date of patent
June 25, 2019
Patent application number
15691408
Date Filed
August 30, 2017
Patent primary examiner
‌
Shawquia Jackson

Find more entities like US Patent 10329298 Inhibitors of cellular metabolic processes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.